Drug Shortage Report for MITOMYCIN FOR INJECTION
Report ID | 65987 |
Drug Identification Number | 02230451 |
Brand name | MITOMYCIN FOR INJECTION |
Common or Proper name | MITOMYCIN |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MITOMYCIN |
Strength(s) | 20MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVESICAL |
Packaging size | 1 |
ATC code | L01DC |
ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-05-01 |
Actual start date | 2020-05-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-10-14 |
Company comments | Item is on suspended supply |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2021-10-14 | French | Compare |
v9 | 2021-10-14 | English | Compare |
v8 | 2020-07-10 | French | Compare |
v7 | 2020-07-10 | English | Compare |
v6 | 2020-07-10 | English | Compare |
v5 | 2020-05-02 | English | Compare |
v4 | 2019-07-29 | French | Compare |
v3 | 2019-07-29 | English | Compare |
v2 | 2018-11-01 | French | Compare |
v1 | 2018-11-01 | English | Compare |
Showing 1 to 10 of 10